<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName archivearticle3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Sci</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Sci</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1349-7006</journal-id><journal-id journal-id-type="publisher-id">CAS</journal-id><journal-title-group><journal-title>Cancer Science</journal-title></journal-title-group><issn pub-type="ppub">1347-9032</issn><issn pub-type="epub">1349-7006</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5448597</article-id><article-id pub-id-type="doi">10.1111/cas.13215</article-id><article-id pub-id-type="publisher-id">CAS13215</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Articles</subject><subj-group subj-group-type="heading"><subject>Cell, Molecular, and Stem Cell Biology</subject></subj-group></subj-group></article-categories><title-group><article-title>
<styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub> plays critical roles in the regulation of focal adhesion dynamics of <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 breast cancer cells</article-title><alt-title alt-title-type="left-running-head">Fukumoto <italic>et al</italic>.</alt-title></title-group><contrib-group><contrib id="cas13215-cr-0001" contrib-type="author"><name><surname>Fukumoto</surname><given-names>Miki</given-names></name><xref ref-type="aff" rid="cas13215-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="cas13215-cr-0002" contrib-type="author" corresp="yes"><name><surname>Ijuin</surname><given-names>Takeshi</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0618-1776</contrib-id><address><email>tijuin@med.kobe-u.ac.jp</email></address><xref ref-type="aff" rid="cas13215-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="cas13215-cr-0003" contrib-type="author"><name><surname>Takenawa</surname><given-names>Tadaomi</given-names></name><xref ref-type="aff" rid="cas13215-aff-0003">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="cas13215-aff-0001"><label><sup>1</sup></label><named-content content-type="organisation-division">The Integrated Center for Mass Spectrometry</named-content><institution>Kobe University Graduate School of Medicine</institution><named-content content-type="city">Kobe</named-content><country country="JP">Japan</country></aff><aff id="cas13215-aff-0002"><label><sup>2</sup></label><named-content content-type="organisation-division"> Division of Biochemistry</named-content><institution>Kobe University Graduate School of Medicine</institution><named-content content-type="city">Kobe</named-content><country country="JP">Japan</country></aff><aff id="cas13215-aff-0003"><label><sup>3</sup></label><named-content content-type="organisation-division">Division of Molecular and Cell Biology</named-content><institution>Kobe University Graduate School of Medicine</institution><named-content content-type="city">Kobe</named-content><country country="JP">Japan</country></aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Takeshi Ijuin, Division of Biochemistry, Kobe University Graduate School of Medicine, 7&#x02010;5&#x02010;1 Kusunoki, Chu&#x02010;o, Kobe, 650&#x02010;0017, Japan.<break/>
Tel: +81&#x02010;78&#x02010;382&#x02010;5429; Fax: +81&#x02010;78&#x02010;382&#x02010;5439;<break/>
E&#x02010;mail: <email>tijuin@med.kobe-u.ac.jp</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="ppub"><month>5</month><year>2017</year></pub-date><volume>108</volume><issue>5</issue><issue-id pub-id-type="doi">10.1111/cas.2017.108.issue-5</issue-id><fpage>941</fpage><lpage>951</lpage><history><date date-type="received"><day>20</day><month>10</month><year>2016</year></date><date date-type="rev-recd"><day>17</day><month>2</month><year>2017</year></date><date date-type="accepted"><day>22</day><month>2</month><year>2017</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 Japanese Cancer Association <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2017 The Authors. Cancer Science published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japanese Cancer Association.</copyright-statement><license license-type="creativeCommonsBy-nc-nd"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution&#x02010;NonCommercial&#x02010;NoDerivs</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#x02010;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:CAS-108-941.pdf"/><abstract id="cas13215-abs-0001"><p>Phosphoinositides play pivotal roles in the regulation of cancer cell phenotypes. Among them, phosphatidylinositol 3,4&#x02010;bisphosphate (<styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub>) localizes to the invadopodia, and positively regulates tumor cell invasion. In this study, we examined the effect of <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub> on focal adhesion dynamics in <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 basal breast cancer cells. Knockdown of <styled-content style="fixed-case">SHIP</styled-content>2, a phosphatidylinositol 3,4,5&#x02010;trisphosphatase (<styled-content style="fixed-case">PIP</styled-content>
<sub>3</sub>) 5&#x02010;phosphatase that generates <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub>, in <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 breast cancer cells, induced the development of focal adhesions and cell spreading, leading to the suppression of invasion. In contrast, knockdown of <styled-content style="fixed-case">PTEN</styled-content>, a 3&#x02010;phosphatase that de&#x02010;phosphorylates <styled-content style="fixed-case">PIP</styled-content>
<sub>3</sub> and <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub>, induced cell shrinkage and increased cell invasion. Interestingly, additional knockdown of <styled-content style="fixed-case">SHIP</styled-content>2 rescued these phenotypes. Overexpression of the <styled-content style="fixed-case">TAPP</styled-content>1 <styled-content style="fixed-case">PH</styled-content> domain, which binds to <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub>, and knockdown of Lpd, a downstream effector of <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub>, resulted in similar phenotypes to those induced by <styled-content style="fixed-case">SHIP</styled-content>2 knockdown. Taken together, our results suggest that inhibition of <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub> generation and/or downstream signaling could be useful for inhibiting breast cancer metastasis.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="cas13215-kwd-0001">Cell invasion</kwd><kwd id="cas13215-kwd-0002">focal adhesion</kwd><kwd id="cas13215-kwd-0003">Lpd</kwd><kwd id="cas13215-kwd-0004"><styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub></kwd><kwd id="cas13215-kwd-0005"><styled-content style="fixed-case">SHIP</styled-content>2</kwd></kwd-group><funding-group><award-group><funding-source>Japan Society for the Promotion of Science</funding-source><award-id>16K08585</award-id></award-group></funding-group><counts><fig-count count="8"/><table-count count="0"/><page-count count="11"/><word-count count="6768"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>cas13215</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2017</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.0.9 mode:remove_FC converted:30.05.2017</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="cas13215-cit-1001">
<source>Cancer Sci</source>
<volume>108</volume> (<year>2017</year>) <fpage>941</fpage>&#x02013;<lpage>951</lpage>
</mixed-citation>
</p></notes><notes><fn-group id="cas13215-ntgp-0001"><fn fn-type="funding" id="cas13215-note-1001"><p>
<bold>Funding Information</bold>
</p><p>This work was supported by grants to T. I. from the Japan Society for the Promotion of Science (JSPS; Kakenhi grant number 16K08585).</p></fn></fn-group></notes></front><body><p>Breast cancer metastasis is one of the major causes of cancer&#x02010;related mortality in women worldwide. Metastasis is a multistep process: after cell spreading, cancer cells form lamellipodia and migrate through the assembly of branched F&#x02010;actin networks. This cytoskeletal rearrangement is mediated by actin&#x02010;regulatory proteins including Rac1, WAVEs, and Mena/Ena/VASP proteins. Mena is frequently upregulated in breast cancer cells and promotes cell invasion. Lamellipodin (Lpd, also referred to as Raph1) localizes to lamellipodia and recruits Mena/Ena/VASP to membrane protrusions.<xref rid="cas13215-bib-0001" ref-type="ref">1</xref> Lpd was shown to regulate random motility in breast cancer cells and is required for lamellipodia formation.<xref rid="cas13215-bib-0002" ref-type="ref">2</xref>, <xref rid="cas13215-bib-0003" ref-type="ref">3</xref>
</p><p>PI3&#x02010;kinase (PI3K) signaling has critical roles in cell proliferation, survival, and motility. PIP<sub>3</sub>, generated from PI(4,5)P<sub>2</sub> through PI3K activity, is an important secondary messenger involved in the activation of Akt. A high proportion of breast cancer cells acquire the ability to activate and sustain PI3K/Akt signaling, which contributes to therapeutic resistance. More than 70% of breast cancers have alterations in at least one component of the PI3K/Akt pathway, including PIK3CA, PTEN, and Akt.<xref rid="cas13215-bib-0004" ref-type="ref">4</xref>, <xref rid="cas13215-bib-0005" ref-type="ref">5</xref>, <xref rid="cas13215-bib-0006" ref-type="ref">6</xref> Among them, <italic>PIK3CA</italic>, the gene that encodes the catalytic subunit of Class 1 PI3K, is mutated and activated in breast cancers.<xref rid="cas13215-bib-0007" ref-type="ref">7</xref>, <xref rid="cas13215-bib-0008" ref-type="ref">8</xref> These mutations, most frequently observed in estrogen and/or progesterone receptor&#x02010;positive and HER2&#x02010;positive breast tumors, but rarely identified in triple&#x02010;negative tumors,<xref rid="cas13215-bib-0009" ref-type="ref">9</xref> lead to the activation of PI3K/Akt signaling, resulting in the initiation of breast cancer. PTEN, a tumor suppressor that hydrolyzes PIP<sub>3</sub> to PI(4,5)P<sub>2</sub> suppresses PI3K/Akt signaling.<xref rid="cas13215-bib-0010" ref-type="ref">10</xref>, <xref rid="cas13215-bib-0011" ref-type="ref">11</xref> Although PTEN mutations are less frequent, loss of heterozygosity at the <italic>PTEN</italic> locus frequently occurs in breast cancer.<xref rid="cas13215-bib-0009" ref-type="ref">9</xref>, <xref rid="cas13215-bib-0012" ref-type="ref">12</xref> PTEN loss is observed in 30&#x02013;40% of sporadic cases of breast cancer that are associated with hyperactivation of PI3K/Akt signaling, and results in the accumulation of PIP<sub>3</sub>
<xref rid="cas13215-bib-0013" ref-type="ref">13</xref>, <xref rid="cas13215-bib-0014" ref-type="ref">14</xref> and tumor progression.<xref rid="cas13215-bib-0015" ref-type="ref">15</xref>, <xref rid="cas13215-bib-0016" ref-type="ref">16</xref> In addition, the phosphoinositide 4&#x02010;phosphatase, INPP4B, which hydrolyzes PI(3,4)P<sub>2</sub> to PI(3)P, inhibits PI3K/Akt signaling, and was identified as a tumor suppressor in breast cancer.<xref rid="cas13215-bib-0017" ref-type="ref">17</xref>, <xref rid="cas13215-bib-0018" ref-type="ref">18</xref> In 84% of basal&#x02010;like breast cancers, loss of INPP4B expression occurs<xref rid="cas13215-bib-0017" ref-type="ref">17</xref> and INPP4B loss&#x02010;of&#x02010;heterogeneity frequently occurs in BRCA1&#x02010;mutant and triple&#x02010;negative basal&#x02010;like breast cancers.<xref rid="cas13215-bib-0018" ref-type="ref">18</xref> INPP4B knockdown was shown to induce Akt activation and anchorage&#x02010;independent growth.<xref rid="cas13215-bib-0018" ref-type="ref">18</xref> In addition, loss of heterogeneity at the <italic>INPP4B</italic> locus was found in the majority of estrogen receptor&#x02010;negative basal&#x02010;like breast cancers.<xref rid="cas13215-bib-0017" ref-type="ref">17</xref>
</p><p>Recent studies identified that a number of phosphoinositide 5&#x02010;phosphatases that hydrolyze PIP<sub>3</sub> to PI(3,4)P<sub>2</sub>, such as SHIP, SKIP, and PIPP, were also found to act as PI3K/Akt signal terminators. The expression of SKIP (also referred to as INPP5K) can be altered in brain cancers.<xref rid="cas13215-bib-0019" ref-type="ref">19</xref>, <xref rid="cas13215-bib-0020" ref-type="ref">20</xref>, <xref rid="cas13215-bib-0021" ref-type="ref">21</xref> In PTEN&#x02010;null glioblastoma cells, SKIP overexpression inhibits cell migration through regulation of the actin cytoskeleton.<xref rid="cas13215-bib-0022" ref-type="ref">22</xref> PIPP (INPP5J) is frequently inactivated in triple&#x02010;negative breast cancers, and functions as a tumor suppressor.<xref rid="cas13215-bib-0023" ref-type="ref">23</xref> Its inactivation promotes tumor growth and suppresses metastasis.<xref rid="cas13215-bib-0023" ref-type="ref">23</xref> The SH2 domain&#x02010;containing inositol 5&#x02010;phosphatase SHIP2, also referred to as INPPL1, which dephosphorylates PIP<sub>3</sub> and PI(4,5)P<sub>2</sub> to generate PI(3,4)P<sub>2</sub> and PI(4)P, respectively, has a negative effect on PI3K/Akt signaling.<xref rid="cas13215-bib-0024" ref-type="ref">24</xref>, <xref rid="cas13215-bib-0025" ref-type="ref">25</xref> SHIP2 knockout mice show mild insulin hypersensitivity and resistance to high fat diet&#x02010;induced obesity.<xref rid="cas13215-bib-0026" ref-type="ref">26</xref> This protein is overexpressed in human breast cancers, and correlates with shorter survival.<xref rid="cas13215-bib-0027" ref-type="ref">27</xref> SHIP2 localizes to the focal contacts and lamellipodia,<xref rid="cas13215-bib-0027" ref-type="ref">27</xref>, <xref rid="cas13215-bib-0028" ref-type="ref">28</xref> and it inhibits cell migration in PTEN&#x02010;null 1321 N1 glioblastoma cells through de&#x02010;phosphorylation of PI(4,5)P<sub>2.</sub>
<xref rid="cas13215-bib-0029" ref-type="ref">29</xref>, <xref rid="cas13215-bib-0030" ref-type="ref">30</xref> In contrast, a number of studies have suggested that SHIP2 is often amplified in human cancer cells,<xref rid="cas13215-bib-0031" ref-type="ref">31</xref>, <xref rid="cas13215-bib-0032" ref-type="ref">32</xref>, <xref rid="cas13215-bib-0033" ref-type="ref">33</xref> whereas the tumor suppressors PTEN and INPP4B are often mutated or deleted, which leads to sustained activation of PIP<sub>3</sub>&#x02010;dependent Akt signaling in these cells. However, it is not clear how amplification of SHIP2 is involved in the malignancy of cancer cells, though this event is expected to lead to decreased PIP<sub>3</sub> levels.</p><p>Increasing evidence suggests that PI(3,4)P<sub>2</sub>, which is generated from PIP<sub>3</sub>, not only induces the activation of Akt, but can act independently to regulate processes such as of membrane ruffle formation,<xref rid="cas13215-bib-0034" ref-type="ref">34</xref> podosome formation,<xref rid="cas13215-bib-0027" ref-type="ref">27</xref> lamellipodia formation,<xref rid="cas13215-bib-0001" ref-type="ref">1</xref> and lamellipodia maturation.<xref rid="cas13215-bib-0035" ref-type="ref">35</xref> Recent study showed that PI(3,4)P<sub>2</sub> depletion impairs motility during B cell chemotaxis, and that Lpd, whose PH domain specifically binds to PI(3,4)P<sub>2</sub>, co&#x02010;localizes with PI(3,4)P<sub>2</sub> to mediate directional migration.<xref rid="cas13215-bib-0036" ref-type="ref">36</xref> Thus, PI(3,4)P<sub>2</sub> is an important signaling molecule that is involved in regulating cytoskeletal rearrangements at the plasma membrane.<xref rid="cas13215-bib-0037" ref-type="ref">37</xref> Other studies have demonstrated the role of Lpd in the actin cytoskeletal network. Lpd and Ena/VASP were found to interact with the WAVE regulatory complex,<xref rid="cas13215-bib-0003" ref-type="ref">3</xref>, <xref rid="cas13215-bib-0038" ref-type="ref">38</xref> membrane&#x02010;bound Lpd directly binds to filamentous actin and recruits Ena/VASP, and WAVE activities the lamellipodial actin network.<xref rid="cas13215-bib-0039" ref-type="ref">39</xref>
</p><p>Focal adhesions (FAs) are macromolecular assemblies that sense extracellular stimuli and signaling complexes that play central roles in cell migration.<xref rid="cas13215-bib-0040" ref-type="ref">40</xref> Upon mechanical tension, some grow into larger and stable FAs and recruit various proteins including zyxin (ZYX) through a process known as FA maturation to modulate integrin signaling for cell migration.<xref rid="cas13215-bib-0041" ref-type="ref">41</xref> Lpd and several focal adhesion proteins, including focal adhesion kinase (FAK), the adapter proteins p130Cas (Cas), and paxillin (PAX), play a role in transducing ECM stiffness into intracellular stiffness.<xref rid="cas13215-bib-0042" ref-type="ref">42</xref> The information encoded by ECM stiffness is transduced into intracellular stiffness by integrins, the transmembrane adhesion receptors for ECM proteins, focal adhesion proteins, and the actin cytoskeleton. Vinculin, a focal adhesion protein that binds to PI(4,5)P<sub>2</sub>, has been implicated in the stiffness&#x02010;sensing event.<xref rid="cas13215-bib-0043" ref-type="ref">43</xref> However, it is still unclear whether PI(3,4)P<sub>2</sub> and its effector protein Lpd regulate focal adhesion dynamics and migration in breast cancer cells.</p><p>We hypothesized that PI(3,4)P<sub>2</sub> has a pivotal role in focal adhesion dynamics and lamellipodia formation, leading to increased motility and invasion in cancer cells. In this study, we examined the effect of SHIP2 and/or PTEN knockdown on the dynamic regulation of focal adhesion formation and the invasion of <italic>PTEN</italic>&#x02010;positive and <italic>INPP4B</italic>&#x02010;null MDA&#x02010;MB&#x02010;231 basal breast cancer cells, and found that knockdown of SHIP2 decreased PI(3,4)P<sub>2</sub> levels, which in turn induced the development of FA and the suppression of invasion. Our results indicate that the PI(3,4)P<sub>2</sub>&#x02010;Lpd dependent pathway, but not the PI(4,5)P<sub>2</sub>&#x02010;FAK signaling pathway, controls focal adhesion dynamics in breast cancer cells.</p><sec id="cas13215-sec-0002"><title>Materials and methods</title><sec id="cas13215-sec-0003"><title>Reagents and antibodies</title><p>The anti&#x02010;phospho&#x02010;FAK (Tyr&#x02010;397) antibody (Catalog No. 44&#x02010;624G) was purchased from Life Technologies (Carlsbad, CA, USA). Anti&#x02010;FAK antibody (Catalog No. 610087) was purchased from BD Transduction Laboratories (San Jose, CA. USA). Anti&#x02010;pan Akt (Catalog No. 5084) and anti&#x02010;phospho&#x02010;Akt (Ser&#x02010;473, Catalog No. 4060) antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). The anti&#x02010;zyxin (ZYX) (Catalog No. HPA004835) and anti&#x02010;vinculin (VCL) (Catalog No. V9131) antibodies were purchased from Sigma&#x02010;Aldrich (St. Louis, MO, USA). The anti&#x02010;SHIP2 (Catalog No. 2839) and anti&#x02010;phospho&#x02010;paxillin (PAX) (Tyr&#x02010;118, Catalog No. 2541) antibodies were purchased from Cell Signaling Technology. The anti&#x02010;paxillin antibody (Catalog No. 610051) was from BD Biosciences (San Jose, CA. USA). The anti&#x02010;actin antibody (Catalog No. MAB1501) was purchased from EMD Millipore (Billerica, MA, USA). LY294002 and wortmannin were purchased from Merck Millipore (Darmstadt, Germany).</p></sec><sec id="cas13215-sec-0004"><title>Cell culture</title><p>The human breast cancer MDA&#x02010;MB&#x02010;231 cell line was purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM, Wako, Osaka, Japan) supplemented with 10% fetal bovine serum (FBS), 4 mM L&#x02010;glutamine, streptomycin, and penicillin.</p></sec><sec id="cas13215-sec-0005"><title>Plasmids and transfection</title><p>Full&#x02010;length human SHIP2 cDNA were obtained by reverse transcription (RT)&#x02010;polymerase chain reaction (PCR) using total RNA isolated from MDA&#x02010;MB&#x02010;231 cells as a template. cDNA was cloned into pEGFP&#x02010;C1 vector (Takara bio, Otsu, Japan). Furthermore, cDNA encoding TAPP1 PH, FAPP1 PH, PLC&#x003b4;1 PH, and Grp1 PH were isolated as described previously.<xref rid="cas13215-bib-0044" ref-type="ref">44</xref>
</p></sec><sec id="cas13215-sec-0006"><title>RNA interference (RNAi)</title><p>The following stealth siRNA species (Life Technologies) targeting human SHIP2, PTEN, and Lpd were used for RNAi experiments. The targeted sequences of the Stealth siRNA species used in this study are as follows: control, Stealth RNAi siRNA negative control med GC (Catalog No. 12935&#x02010;300), SHIP2 #1, 5&#x02032;&#x02010; CAGGAGAUCCUGAACUACAUCAGCA&#x02010;3&#x02032;, SHIP2 #2, 5&#x02032;&#x02010;GAGGUUGGAGUUACCUCCCAGUUCA&#x02010;3&#x02032;, PTEN, 5&#x02032;&#x02010;CCAAUGGCUAAGUGAAGAUGACAAU&#x02010;3&#x02032;, Lpd #1, 5&#x02032;&#x02010;CCAGCUGGAUCAUGUCAACGUUUAU&#x02010;3&#x02032;, and Lpd #2, 5&#x02032;&#x02010;GCAAAGUAUGGGAAGCAGCUCUAUA&#x02010;3&#x02032;. siRNA was transfected into MDA&#x02010;MB&#x02010;231 cells using Lipofectamine RNAiMAX reagent (Life Technologies) according to the manufacturer's protocol.</p></sec><sec id="cas13215-sec-0007"><title>Immunofluorescence microscopy</title><p>Cells were transfected with plasmids or siRNA for 24&#x02013;48 h and then re&#x02010;plated on fibronectin (FN)&#x02010;coated coverslips. Cells were cultured for 24 h, and then fixed with 4% paraformaldehyde for 10 min at room temperature, which was followed by permeabilization with phosphate&#x02010;buffered saline (PBS) containing 0.2% Triton X&#x02010;100 for 5 min. Coverslips were washed twice with PBS and then incubated with primary antibody for 1 h at room temperature. Alexa Fluor 568&#x02010;conjugated anti&#x02010;rabbit IgG or anti&#x02010;mouse antibodies (Life Technologies) were used as secondary antibodies. The coverslips were mounted with PermaFluor Aqueous Mounting Medium (Thermo Scientific, Waltham, MA, USA) and analyzed using a FluoView 1000&#x02010;D confocal microscope (Olympus, Tokyo, Japan).</p></sec><sec id="cas13215-sec-0008"><title>Western blotting</title><p>MDA&#x02010;MB&#x02010;231 cells cultured in FN&#x02010;coated dishes were lysed with Laemmli sample buffer, briefly sonicated, and boiled at 95&#x000b0;C for 5 min. Western blotting was performed by standard procedures with detection using alkaline phosphatase&#x02010;conjugated secondary antibodies (Promega, Madison, MI, USA).</p></sec><sec id="cas13215-sec-0009"><title>Quantification of focal adhesions and cell area</title><p>The number of focal adhesions was calculated as follows. Cells were immunostained with anti&#x02010;PAX or anti&#x02010;VCL antibody. The number of PAX&#x02010; or VCL&#x02010;positive plaques per cell was counted using ImageJ software (National Institute of Health, Bethesda, MD, USA). Eighty cells were analyzed for each experiment. For the quantification of cell area, cells were immunostained with rhodamine&#x02010; or Alexa Fluor 647&#x02010;conjugated phalloidin and were imaged by confocal microscopy. Eighty cells were used to quantify cell area.</p></sec><sec id="cas13215-sec-0010"><title>Matrigel invasion assay</title><p>The invasion assay was performed as previously described. MDA&#x02010;MB&#x02010;231 cells were seeded in the upper compartment of a BD Biocoat Matrigel Invasion Chamber (BD Biosciences) and incubated with DMEM containing 10% FBS in the lower well and serum&#x02010;deprived medium in the top chamber. After 22 h, the cells were fixed with 3.7% formaldehyde in PBS for 30 min. Cells were washed with PBS and cells on the undersurface of the filter were observed by confocal microscopy.</p></sec><sec id="cas13215-sec-0011"><title>Statistical analysis</title><p>For multiple comparisons, <italic>P</italic>&#x02010;values were generated by one&#x02010;way analysis of variance using the Student&#x02010;Newman&#x02010;Keuls multiple comparison tests. For two group analysis, <italic>P</italic>&#x02010;values were calculated by Student's <italic>t</italic>&#x02010;test.</p></sec><sec id="cas13215-sec-0012"><title>Quantification of phosphoinositides</title><p>Plasma membrane phosphoinositides were quantified as follows. To measure PI(3,4)P<sub>2</sub>, PI(4,5)P<sub>2</sub>, and PIP<sub>3</sub> levels, the laser intensity of EGFP&#x02010;TAPP1 PH, &#x02010;PLC&#x003b4;1 PH, and &#x02013;GRP1 PH, respectively, were analyzed using the Trainable Weka Segmentation plugin with Image J software.</p></sec></sec><sec id="cas13215-sec-0013"><title>Results</title><sec id="cas13215-sec-0014"><title>SHIP2 knockdown increases the number of focal adhesions and cell area</title><p>Focal adhesions that connect the actin cytoskeleton with the extracellular matrix and focal adhesion&#x02010;associated proteins such as Akt, FAK, and PAX, regulate cell invasion, metastasis, and migration.<xref rid="cas13215-bib-0045" ref-type="ref">45</xref>, <xref rid="cas13215-bib-0046" ref-type="ref">46</xref>, <xref rid="cas13215-bib-0047" ref-type="ref">47</xref> These proteins are localized to focal adhesions and are phosphorylated upon focal adhesion development.<xref rid="cas13215-bib-0047" ref-type="ref">47</xref>, <xref rid="cas13215-bib-0048" ref-type="ref">48</xref>, <xref rid="cas13215-bib-0049" ref-type="ref">49</xref> We examined the effect of SHIP2 silencing in MDA&#x02010;MB&#x02010;231 breast cancer cells on the expression and activation of Akt, FAK, and PAX. SHIP2 knockdown increased the phosphorylation of PAX at Tyr&#x02010;118, which is involved in mature focal adhesion formation (Fig. <xref rid="cas13215-fig-0001" ref-type="fig">1</xref>a), without affecting phosphorylation of FAK at Tyr&#x02010;397, and Akt at Ser&#x02010;473. Since Akt phosphorylation is dependent on PIP<sub>3</sub>, these results imply that SHIP2 knockdown increases PIP<sub>3</sub> levels by a very small amount. Next, the effect of SHIP2 knockdown on focal adhesion formation was examined. MDA&#x02010;MB&#x02010;231 cells exhibited an elongated shape with polarized membranes, reflecting a highly invasive phenotype. The number of VCL&#x02010; and ZYX&#x02010; positive focal adhesions increased after SHIP2 knockdown (Fig. <xref rid="cas13215-fig-0001" ref-type="fig">1</xref>b,c). In these cells, stress fibers formed and the cell area also increased (Fig. <xref rid="cas13215-fig-0001" ref-type="fig">1</xref>b,d).</p><fig fig-type="Figure" xml:lang="en" id="cas13215-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Effect of <styled-content style="fixed-case">SHIP</styled-content>2 knockdown on focal adhesion formation and cell morphology in <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells. (a) Lysates from control (&#x02212;) or <styled-content style="fixed-case">SHIP</styled-content>2 si<styled-content style="fixed-case">RNA</styled-content>&#x02010;transfected <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells were subjected to western blot analysis using antibodies against <styled-content style="fixed-case">SHIP</styled-content>2, <styled-content style="fixed-case">FAK</styled-content>, phospho&#x02010;<styled-content style="fixed-case">FAK</styled-content>, Akt, phospho&#x02010;Akt (Ser&#x02010;473), <styled-content style="fixed-case">PAX</styled-content>, phospho&#x02010;<styled-content style="fixed-case">PAX</styled-content>, and actin. (b) <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells transfected with the indicated antibodies were stained with vinculin (<styled-content style="fixed-case">VCL</styled-content>) and zyxin (<styled-content style="fixed-case">ZYX</styled-content>) antibodies. F&#x02010;actin was visualized with Alexa Fluor 647 labeled&#x02010;phalloidin. Scale bar = 10 &#x003bc;m. (c) Quantification of focal adhesion number per cell from (b). (d) Measurement of cell area of cells from (b). All data represent the mean &#x000b1; <styled-content style="fixed-case">SD</styled-content> of 18 cells for the control, 16 cells for si<styled-content style="fixed-case">SHIP</styled-content>2 #1, and 16 cells for si<styled-content style="fixed-case">SHIP</styled-content>2 #2. *<italic>P</italic> &#x0003c; 0.05.</p></caption><graphic id="nlm-graphic-3" xlink:href="CAS-108-941-g001"/></fig></sec><sec id="cas13215-sec-0015"><title>SHIP2 alters PI(3,4)P<sub>2</sub> at focal contacts</title><p>To examine whether SHIP2 hydrolyzes PIP<sub>3</sub> at focal contacts, GFP&#x02010;SHIP2 was expressed in MDA&#x02010;MB&#x02010;231 cells. This protein was localized to the lamellipodia and VCL&#x02010;positive focal contacts (Fig. <xref rid="cas13215-fig-0002" ref-type="fig">2</xref>a). Since focal contacts and lamellipodia are formed during the initial stages of cell spreading before the development of focal adhesions, these results imply a role of SHIP2 in the assembly and/or disassembly of focal contacts. Next, the localization of PIP<sub>3</sub> and PI(3,4)P<sub>2</sub> were observed using GFP&#x02010;GRP1 PH and GFP&#x02010;TAPP1 PH, which specifically bind to PIP<sub>3</sub> and PI(3,4)P<sub>2</sub>, respectively.<xref rid="cas13215-bib-0050" ref-type="ref">50</xref> PIP<sub>3</sub> was predominantly localized to the lamellipodia and focal contacts at the front of cells in both control&#x02010; and SHIP2 siRNA&#x02010;transfected cells (Fig. <xref rid="cas13215-fig-0002" ref-type="fig">2</xref>b). In addition, PI(3,4)P<sub>2</sub> was localized to the lamellipodia and partially to VCL&#x02010;positive focal contacts. In SHIP2 knockdown cells, VCL&#x02010;positive focal contacts were observed and PI(3,4)P<sub>2</sub> localization was no longer observed (Fig. <xref rid="cas13215-fig-0002" ref-type="fig">2</xref>b). Because SHIP2 also controls PI(4,5)P<sub>2</sub> and PI(4)P at the plasma membrane in 1321 N1 glioblastoma cells,<xref rid="cas13215-bib-0030" ref-type="ref">30</xref> the effect of SHIP2 knockdown on these phosphoinositides at the plasma membrane was examined. Representative images of GFP&#x02010;FAPP1 PH and GFP&#x02010;PLC&#x003b4;1 PH, which bind to PI(4)P and PI(4,5)P<sub>2</sub>, are shown. Localization of these phosphoinositides at the PM was not changed by SHIP2 depletion in MDA&#x02010;MB&#x02010;231 cells (Fig. <xref rid="cas13215-fig-0002" ref-type="fig">2</xref>c). To examine the effect of PIP<sub>3</sub> generation on focal adhesion formation, MDA&#x02010;MB&#x02010;231 cells were treated with PI3&#x02010;kinase inhibitors including wortmannin and LY294002. These compounds completely inhibited PIP<sub>3</sub>&#x02010;dependent Akt phosphorylation, showing complete abolishment of PIP<sub>3</sub> generation (Fig. <xref rid="cas13215-fig-0003" ref-type="fig">3</xref>a). These inhibitors increased PAX phosphorylation (Fig. <xref rid="cas13215-fig-0003" ref-type="fig">3</xref>a) and increased focal adhesions number and cell areas (Fig. <xref rid="cas13215-fig-0003" ref-type="fig">3</xref>b&#x02013;d). To clarify whether PI(3,4)P<sub>2</sub> contributes to these changes, the effect of PI3&#x02010;kinase inhibitors on relative amount of PI(3,4)P<sub>2</sub> and PI(4,5)P<sub>2</sub> levels at the PM were examined. Fluorescence intensity of EGFP&#x02010;TAPP1 PH domain that binds to PI(3,4)P<sub>2</sub>, has been measured to quantify PI(3,4)P<sub>2</sub> levels at the plasma membrane. We found that PM PI(3,4)P<sub>2</sub> levels were decreased, whereas the fluorescence intensity of EGFP&#x02010;PLC&#x003b4;1 PH that binds to PI(4,5)P<sub>2</sub> was not altered by these inhibitors (Fig. <xref rid="cas13215-fig-0003" ref-type="fig">3</xref>e,f). These results suggest that the generation of PI(3,4)P<sub>2</sub> by SHIP2 promotes the formation of lamellipodia and suppresses the development of focal adhesions, whereas PIP<sub>3</sub> and PI(4,5)P<sub>2</sub> are unlikely to play any role in these processes.</p><fig fig-type="Figure" xml:lang="en" id="cas13215-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Effect of <styled-content style="fixed-case">SHIP</styled-content>2 knockdown on <styled-content style="fixed-case">PIP</styled-content>
<sub>3</sub> and <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub> levels at the focal adhesions. (a) <styled-content style="fixed-case">GFP</styled-content>&#x02010;<styled-content style="fixed-case">SHIP</styled-content>2&#x02010;expressing <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells were stained with a <styled-content style="fixed-case">VCL</styled-content> antibody. Enlarged images of the boxed areas are indicated in the lower panels. The arrows indicate membrane ruffles. Scale bar = 10 &#x003bc;m. (b) <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells transfected with control (siCTL) or SHIP2 #1 (siSHIP2) si<styled-content style="fixed-case">RNA</styled-content> were stained with <styled-content style="fixed-case">VCL</styled-content>. For the detection of <styled-content style="fixed-case">PIP</styled-content>
<sub>3</sub> and <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub>, <styled-content style="fixed-case">GFP</styled-content>&#x02010;<styled-content style="fixed-case">GRP</styled-content>1&#x02010;<styled-content style="fixed-case">PH</styled-content> or <styled-content style="fixed-case">GFP</styled-content>&#x02010;<styled-content style="fixed-case">TAPP</styled-content>1 <styled-content style="fixed-case">PH</styled-content> was also expressed in these cells. F&#x02010;actin was visualized with Alexa Fluor 647 labeled&#x02010;phalloidin. Enlarged images of boxed areas are indicated in the lower panels. The arrows and arrowheads indicate focal adhesions and membrane ruffles, respectively. Scale bar = 10 &#x003bc;m. (c) <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells transfected with Control (siCTL) or SHIP2 #1 (siSHIP2) si<styled-content style="fixed-case">RNA</styled-content> were stained with <styled-content style="fixed-case">VCL</styled-content>. To detect <styled-content style="fixed-case">PI</styled-content>(4,5)P<sub>2</sub> and <styled-content style="fixed-case">PI</styled-content>(4)P, <styled-content style="fixed-case">GFP</styled-content>&#x02010;<styled-content style="fixed-case">PLC</styled-content>&#x003b4;1&#x02010;<styled-content style="fixed-case">PH</styled-content> or <styled-content style="fixed-case">GFP</styled-content>&#x02010;<styled-content style="fixed-case">FAPP</styled-content>1 <styled-content style="fixed-case">PH</styled-content> was also expressed in these cells. F&#x02010;actin was visualized with Alexa Fluor 647 labeled&#x02010;phalloidin. Enlarged images of boxed areas are indicated in the lower panels. The arrows and arrowheads indicate focal adhesions and membrane ruffles, respectively. Scale bar = 10 &#x003bc;m.</p></caption><graphic id="nlm-graphic-5" xlink:href="CAS-108-941-g002"/></fig><fig fig-type="Figure" xml:lang="en" id="cas13215-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Effect of <styled-content style="fixed-case">PI</styled-content>3K inhibitors on focal adhesion formation and cell spreading. (a) Lysates from <styled-content style="fixed-case">DMSO</styled-content>&#x02010;, wortmannin&#x02010;, or <styled-content style="fixed-case">LY</styled-content>294002&#x02010;treated <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells were subjected to western blot analysis using <styled-content style="fixed-case">FAK</styled-content>, phospho&#x02010;<styled-content style="fixed-case">FAK</styled-content>, Akt, phospho&#x02010;Akt, <styled-content style="fixed-case">PAX</styled-content>, phospho&#x02010;<styled-content style="fixed-case">PAX</styled-content>, and actin antibodies. (b) Effect of <styled-content style="fixed-case">PI</styled-content>3K inhibitors on focal adhesion formation. After treatment with <styled-content style="fixed-case">DMSO</styled-content> (<styled-content style="fixed-case">CTL</styled-content>), wortmannin, or <styled-content style="fixed-case">LY</styled-content>294002, cells were fixed and stained with an anti&#x02010;vinculin antibody. Actin was visualized by rhodamine&#x02010;phalloidin. Scale bar = 10 &#x003bc;m. (c,d) Quantification of focal adhesions per cell (c) and measurement of cell area (d) from (b). Data represent the mean &#x000b1; <styled-content style="fixed-case">SD</styled-content> of 30 cells for <styled-content style="fixed-case">CTL</styled-content>, wortmannin, and <styled-content style="fixed-case">LY</styled-content>294002&#x02010;treated cells, respectively. *<italic>P</italic> &#x0003c; 0.05. (e) Quantification of the relative amounts of <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub> at the <styled-content style="fixed-case">PM</styled-content> in <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells treated with <styled-content style="fixed-case">PI</styled-content>3&#x02010;kinase inhibitors. To detect <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub>, <styled-content style="fixed-case">GFP</styled-content>&#x02010;<styled-content style="fixed-case">TAPP</styled-content>1 <styled-content style="fixed-case">PH</styled-content> was expressed in these cells. Cells were stained with an anti&#x02010;vinculin antibody. Actin was visualized by Alexa Fluor 647&#x02010;conjugated phalloidin. Scale bar = 20 &#x003bc;m. Data represent the mean &#x000b1; <styled-content style="fixed-case">SD</styled-content>. <italic>n</italic>, no of analyzed cells pooled from three independent experiments. ***<italic>P</italic> &#x0003c; 0.001. (f) Quantification of the relative amounts of <styled-content style="fixed-case">PI</styled-content>(4,5)P<sub>2</sub> at the <styled-content style="fixed-case">PM</styled-content> in <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells treated with <styled-content style="fixed-case">PI</styled-content>3&#x02010;kinase inhibitors. For the detection of <styled-content style="fixed-case">PI</styled-content>(4,5)P<sub>2</sub>, <styled-content style="fixed-case">GFP</styled-content>&#x02010;<styled-content style="fixed-case">PLC</styled-content>&#x003b4;1&#x02010;<styled-content style="fixed-case">PH</styled-content> was expressed in these cells. Data represent the mean &#x000b1; <styled-content style="fixed-case">SD</styled-content>. <italic>n</italic>, no. analyzed cells pooled from three independent experiments. n.s.: not significant.</p></caption><graphic id="nlm-graphic-7" xlink:href="CAS-108-941-g003"/></fig></sec><sec id="cas13215-sec-0016"><title>Differential effect of PTEN and SHIP2 knockdown on focal adhesion development and cell invasion</title><p>PTEN is a 3&#x02010;phosphatase of PIP<sub>3</sub> and PI(3,4)P<sub>2</sub>, which catalyzes the production of PI(3,4)P<sub>2</sub> and PI(4)P, respectively. We compared the effect of SHIP2 and PTEN knockdown on focal adhesions in MDA&#x02010;MB&#x02010;231 cells. SHIP2 knockdown did not alter Akt phosphorylation, whereas PTEN knockdown increased the levels of phosphorylated Akt (Fig. <xref rid="cas13215-fig-0004" ref-type="fig">4</xref>a). SHIP2 knockdown increased phosphorylated PAX, which was not increased by PTEN knockdown (Fig. <xref rid="cas13215-fig-0004" ref-type="fig">4</xref>a). PTEN silencing induced aberrant membrane ruffle formation and decreased cell area (Fig. <xref rid="cas13215-fig-0004" ref-type="fig">4</xref>b&#x02013;d). Interestingly, the combination with SHIP2 knockdown suppressed these phenotypes (Fig. <xref rid="cas13215-fig-0004" ref-type="fig">4</xref>b&#x02013;d). Compared to that in control cells, the fluorescence intensity of EGFP&#x02010;TAPP1 PH was decreased by 60% in SHIP2&#x02010;depleted cells, increased by 10% in PTEN&#x02010;depleted cells, and decreased by 50% upon combined depletion of SHIP2 and PTEN (Fig. <xref rid="cas13215-fig-0004" ref-type="fig">4</xref>e). Fluorescence intensity of the EGFP&#x02010;PLC&#x003b4;1 PH was increased by 20% in SHIP2&#x02010;depleted cells, and was not changed in PTEN&#x02010;depleted cells (Fig. <xref rid="cas13215-fig-0004" ref-type="fig">4</xref>f). Fluorescence intensities of EGFP&#x02010;FAPP1 PH were not changed in SHIP2&#x02010; or PTEN&#x02010;depleted cells (Fig. <xref rid="cas13215-fig-0004" ref-type="fig">4</xref>g). These results suggest that PI(3,4)P<sub>2</sub> might play an important role in membrane ruffle and lamellipodia formation in MDA&#x02010;MB&#x02010;231 cells. Next, the effect of SHIP2 and/or PTEN knockdown on cell invasion in Matrigel was examined. SHIP2 silencing decreased the number of invasive cells, whereas PTEN&#x02010;silencing increased this parameter (Fig. <xref rid="cas13215-fig-0005" ref-type="fig">5</xref>a,b). Interestingly, combined knockdown of SHIP2 and PTEN suppressed the invasion of MDA&#x02010;MB&#x02010;231 cells (Fig. <xref rid="cas13215-fig-0005" ref-type="fig">5</xref>a,b).</p><fig fig-type="Figure" xml:lang="en" id="cas13215-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Effect of <styled-content style="fixed-case">SHIP</styled-content>2 and <styled-content style="fixed-case">PTEN</styled-content> silencing on focal adhesion&#x02010;related signaling molecules and focal adhesion formation. (a) Phosphorylation of <styled-content style="fixed-case">PAX</styled-content>,<styled-content style="fixed-case"> FAK</styled-content>, and Akt in <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells transfected with <styled-content style="fixed-case">PTEN</styled-content> si<styled-content style="fixed-case">RNA</styled-content> and/or <styled-content style="fixed-case">SHIP</styled-content>2 si<styled-content style="fixed-case">RNA</styled-content>. Lysates were subjected to western blotting with the indicated antibodies. (b) <styled-content style="fixed-case">PTEN</styled-content> and/or <styled-content style="fixed-case">SHIP</styled-content>2&#x02010;silenced <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells were stained with an anti&#x02010;VCL antibody. Actin was visualized with rhodamine&#x02010;phalloidin. Scale bar = 10 &#x003bc;m. (c) Quantification of focal adhesions per cell from (b). (d) Cell area of si<styled-content style="fixed-case">RNA</styled-content>&#x02010;transfected cells from (b). Data represent the mean &#x000b1; <styled-content style="fixed-case">SD</styled-content> of 30 cells for control siRNA, <styled-content style="fixed-case">PTEN</styled-content> si<styled-content style="fixed-case">RNA</styled-content>, si<styled-content style="fixed-case">SHIP</styled-content>2, <styled-content style="fixed-case">PTEN</styled-content> si<styled-content style="fixed-case">RNA</styled-content> and <styled-content style="fixed-case">SHIP</styled-content>2 si<styled-content style="fixed-case">RNA</styled-content>, respectively. *<italic>P</italic> &#x0003c; 0.05. (e) Quantification of the relative amounts of <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub> at the <styled-content style="fixed-case">PM</styled-content> in <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells transfected with <styled-content style="fixed-case">SHIP</styled-content>2 si<styled-content style="fixed-case">RNA</styled-content> and <styled-content style="fixed-case">PTEN</styled-content> si<styled-content style="fixed-case">RNA</styled-content>. To detect <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub>, <styled-content style="fixed-case">GFP</styled-content>&#x02010;<styled-content style="fixed-case">TAPP</styled-content>1 <styled-content style="fixed-case">PH</styled-content>, was expressed in these cells. The representative images were shown and enlarged images of the boxed areas are indicated in the lower panels. Cells were stained with an anti&#x02010;vinculin antibody. Actin was visualized with Alexa Fluor 647&#x02010;conjugated&#x02010;phalloidin. Scale bar = 20 &#x003bc;m. Data represent the mean &#x000b1; <styled-content style="fixed-case">SD</styled-content>. <italic>n</italic>, no. analyzed cells pooled from six independent experiments. **<italic>P</italic> &#x0003c; 0.01, ***<italic>P</italic> &#x0003c; 0.001 (Student&#x02013;Newman&#x02010;Keuls multiple comparison tests). (f,g) Quantification of the relative amounts of <styled-content style="fixed-case">PI</styled-content>(4,5)P<sub>2</sub> (f) and <styled-content style="fixed-case">PI</styled-content>(4)P (g) at the <styled-content style="fixed-case">PM</styled-content> in <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells transfected with PTEN siRNA and/or SHIP2 siRNA. For the detection of <styled-content style="fixed-case">PI</styled-content>(4,5)P<sub>2</sub> and <styled-content style="fixed-case">PI</styled-content>(4)P, <styled-content style="fixed-case">GFP</styled-content>&#x02010;<styled-content style="fixed-case">PLC</styled-content>&#x003b4;1&#x02010;<styled-content style="fixed-case">PH</styled-content> or <styled-content style="fixed-case">GFP</styled-content>&#x02010;<styled-content style="fixed-case">FAPP</styled-content>1 <styled-content style="fixed-case">PH</styled-content> was expressed in these cells. Data represent the mean &#x000b1; <styled-content style="fixed-case">SD</styled-content>. <italic>n</italic>, no. analyzed cells pooled from three independent experiments. *<italic>P</italic> &#x0003c; 0.05 (Student&#x02013;Newman&#x02013;Keuls multiple comparison tests), n.s.: not significant.</p></caption><graphic id="nlm-graphic-9" xlink:href="CAS-108-941-g004"/></fig><fig fig-type="Figure" xml:lang="en" id="cas13215-fig-0005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Effect of <styled-content style="fixed-case">SHIP</styled-content>2 and <styled-content style="fixed-case">PTEN</styled-content> knockdown on cell invasion. (a) An invasion assay was performed using <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells. Cells transfected with PTEN siRNA and/or SHIP2 siRNA were seeded in Matrigel invasion chambers and allowed to invade the Matrigel for 22 h. Invading cells were fixed and stained with propidium iodide. Scale bar = 100 &#x003bc;m. (b) The number of invading cells, shown in (a), was counted. Results represent the mean &#x000b1; <styled-content style="fixed-case">SD</styled-content> of five independent experiments. *<italic>P</italic> &#x0003c; 0.01. n.s.: not significant.</p></caption><graphic id="nlm-graphic-11" xlink:href="CAS-108-941-g005"/></fig></sec><sec id="cas13215-sec-0017"><title>Lpd knockdown increases focal adhesion development</title><p>Lpd has a PH domain, which binds to PI(3,4)P<sub>2</sub>, and plays a crucial role in membrane ruffle and lamellipodia formation through sequential activation of the Rac&#x02010;WAVE pathway.<xref rid="cas13215-bib-0003" ref-type="ref">3</xref>, <xref rid="cas13215-bib-0051" ref-type="ref">51</xref> We thus examined changes in the formation of focal adhesions and lamellipodia after Lpd knockdown. Lpd knockdown slightly increased phospho&#x02010;PAX (Fig. <xref rid="cas13215-fig-0006" ref-type="fig">6</xref>a), induced focal adhesion formation and cell spreading (Fig. <xref rid="cas13215-fig-0006" ref-type="fig">6</xref>b&#x02013;d), and inhibited cell invasion in Matrigel (Fig. <xref rid="cas13215-fig-0006" ref-type="fig">6</xref>e,f). These results are very similar to those of SHIP2 knockdown, and suggest that the inhibition of the PI(3,4)P<sub>2</sub>&#x02010;dependent Lpd&#x02010;Rac&#x02010;WAVE signaling pathway causes a shift from membrane ruffling and lamellipodia formation to focal adhesion development.</p><fig fig-type="Figure" xml:lang="en" id="cas13215-fig-0006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Lpd knockdown results in focal adhesion formation. (a) Phosphorylation of <styled-content style="fixed-case">PAX</styled-content>,<styled-content style="fixed-case"> FAK</styled-content>, and Akt in <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells transfected with control&#x02010; (<styled-content style="fixed-case">CTL</styled-content>) or Lpd&#x02010;targeted si<styled-content style="fixed-case">RNA</styled-content>. Lysates were subjected to western blot analyses with the indicated antibodies. Results are presented as the mean &#x000b1; <styled-content style="fixed-case">SD</styled-content> of three independent experiments. *<italic>P</italic> &#x0003c; 0.01, n.s.: not significant. (b) <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells transfected with control&#x02010; (<styled-content style="fixed-case">CTL</styled-content>) or Lpd&#x02010;targeted si<styled-content style="fixed-case">RNA</styled-content> were stained with anti&#x02010;<styled-content style="fixed-case">VCL</styled-content> and anti&#x02010;<styled-content style="fixed-case">ZYX</styled-content> antibodies. Actin was visualized by Alexa Fluor 647&#x02010;conjugated phalloidin. Scale bar = 10 &#x003bc;m. (c,d) Quantification of focal adhesion number per cell (c) and measurement of cell area (d) from cells shown in (a). Data represent the mean &#x000b1; <styled-content style="fixed-case">SD</styled-content> of 35 cells for the control, siLpd #1, and siLpd #2, respectively. *<italic>P</italic> &#x0003c; 0.01. (e) An invasion assay was performed using <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells. Cells transfected with siLpd #1 or siLpd #2 were seeded in Matrigel invasion chambers and allowed to invade the Matrigel for 22 h. Invading cells were fixed and stained with propidium iodide. Scale bar = 100 &#x003bc;m. (f) The number of invading cells, shown in (e), was counted. Results represent the mean &#x000b1; <styled-content style="fixed-case">SD</styled-content> of three independent experiments. *<italic>P</italic> &#x0003c; 0.01.</p></caption><graphic id="nlm-graphic-13" xlink:href="CAS-108-941-g006"/></fig></sec><sec id="cas13215-sec-0018"><title>PI(3,4)P<sub>2</sub> is required for lamellipodia formation</title><p>We hypothesized that overexpression of TAPP1 PH, which binds to PI(3,4)P<sub>2</sub>, would efficiently suppress Lpd activation leading to lamellipodia formation. To clarify the importance of PI(3,4)P<sub>2</sub> in focal adhesion formation and cell spreading, we examined the effect of TAPP1 PH domain overexpression on these events. GFP&#x02010;TAPP1 PH overexpression induced focal adhesion formation and cell spreading. However, the expression of GFP&#x02010;GRP1 PH did not affect these parameters (Fig. <xref rid="cas13215-fig-0007" ref-type="fig">7</xref>a&#x02013;c). These results show that PI(3,4)P<sub>2</sub> generation promotes cell membrane ruffling and lamellipodia formation, leading to cell invasion, whereas suppression of PI(3,4)P<sub>2</sub> production results in focal adhesion and stress fiber formation, leading to cell spreading and increased cell area.</p><fig fig-type="Figure" xml:lang="en" id="cas13215-fig-0007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Effect of phosphoinositide binding domain expression on focal adhesion formation. (a) Expression of <styled-content style="fixed-case">GFP</styled-content>,<styled-content style="fixed-case"> GFP</styled-content>&#x02010;<styled-content style="fixed-case">TAPP</styled-content>1 <styled-content style="fixed-case">PH</styled-content>, or <styled-content style="fixed-case">GFP</styled-content>&#x02010;<styled-content style="fixed-case">GRP</styled-content>1 <styled-content style="fixed-case">PH</styled-content> in <styled-content style="fixed-case">MDA</styled-content>&#x02010;<styled-content style="fixed-case">MB</styled-content>&#x02010;231 cells to mask <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub> or <styled-content style="fixed-case">PIP</styled-content>
<sub>3</sub>, respectively. The cells were stained with an anti&#x02010;<styled-content style="fixed-case">VCL</styled-content> antibody and actin was visualized with Alexa Fluor 647&#x02010;labeled phalloidin. Scale bar = 10 &#x003bc;m. (b) Quantification of focal adhesions per cell from (a). (c) Cell area of cells from (a). Data represent the mean &#x000b1; <styled-content style="fixed-case">SD</styled-content> of 50 cells for control <styled-content style="fixed-case">GFP</styled-content>, 27 cells for <styled-content style="fixed-case">GFP</styled-content>&#x02010;<styled-content style="fixed-case">TAPP</styled-content>1 <styled-content style="fixed-case">PH</styled-content>, and eight cells for <styled-content style="fixed-case">GFP</styled-content>&#x02010;<styled-content style="fixed-case">GRP</styled-content>1 <styled-content style="fixed-case">PH</styled-content>, respectively. *<italic>P</italic> &#x0003c; 0.01. n.s.: not significant.</p></caption><graphic id="nlm-graphic-15" xlink:href="CAS-108-941-g007"/></fig></sec></sec><sec id="cas13215-sec-0019"><title>Discussion</title><p>Alteration of PI3KCA, PTEN, PIP<sub>3</sub> 5&#x02010;phosphatases, and INPP4B are common events in breast cancer,<xref rid="cas13215-bib-0005" ref-type="ref">5</xref>, <xref rid="cas13215-bib-0006" ref-type="ref">6</xref> suggesting the importance of phosphoinositides in tumorigenesis. In this study, we revealed that PI(3,4)P<sub>2</sub>, rather than PIP<sub>3</sub>, is important for lamellipodia formation in human cancer cells, which leads to cell motility and invasion. In basal&#x02010;breast cancer cell line<strike>s</strike>, and specifically MDA&#x02010;MB&#x02010;231 cells, which lack INPP4B, intracellular PIP<sub>3</sub> and PI(3,4)P<sub>2</sub> amounts are under the control of PTEN and PIP<sub>3</sub> phosphatases including SHIP2. SHIP2 expression is elevated in breast cancer cells promoting cell migration and tumor metastasis. The function of SHIP2 in glioblastoma cell migration has been previously evaluated.<xref rid="cas13215-bib-0030" ref-type="ref">30</xref> SHIP2&#x02010;depletion potentiated migration in PTEN&#x02010;null 1321 N1 glioblastoma cells, whereas it reduced migration in PTEN&#x02010;containing LN229 cells.<xref rid="cas13215-bib-0030" ref-type="ref">30</xref> These results are not consistent because SHIP2 functions as an oncogene. However, it also functions as a tumor suppressor in different cancer cells, which might be explained by different functions of PIP<sub>3</sub> and PI(3,4)P<sub>2</sub> in cancer cells. Therefore, it was suggested that the effect of SHIP2 on cell migration is dependent on cell types and is affected by PTEN status. Here, we show that in MDA&#x02010;MB&#x02010;231 breast cancer cells, SHIP2&#x02010;depletion increased focal adhesion formation and cell area regardless of PTEN expression levels (Figs <xref rid="cas13215-fig-0004" ref-type="fig">4</xref>b&#x02013;d), suggesting that PI(3,4)P<sub>2</sub> generated by SHIP2 acts on focal adhesion dynamics and cell invasion. Akt phosphorylation was not markedly increased by SHIP2 knockdown in contrast to PTEN knockdown, indicating that PIP<sub>3</sub> levels were not significantly affected by SHIP2. In contrast, knockdown of PTEN enhanced Akt phosphorylation markedly with slight increases in cell adhesion formation and cell invasion. These results suggest that PTEN knockdown increases PIP<sub>3</sub>, and slightly increases PI(3,4)P<sub>2</sub> levels, in these cells. Treatment of PI 3&#x02010;kinase inhibitors decreased PIP<sub>3</sub> and PI(3,4)P<sub>2</sub> generation, which in turn resulted in an increased number of focal adhesions and cell area. Taken together, PIP<sub>3</sub> and PI(3,4)P<sub>2</sub> have distinct roles in basal breast cancer phenotypes (Fig. <xref rid="cas13215-fig-0008" ref-type="fig">8</xref>). In MDA&#x02010;MB&#x02010;231 cells, which have high PTEN expression,<xref rid="cas13215-bib-0052" ref-type="ref">52</xref> PTEN predominantly regulates PIP<sub>3</sub> levels, and is related to PI3&#x02010;kinase signaling. In contrast, SHIP2 plays a role in the generation of PI(3,4)P<sub>2</sub>, which in turn leads to Lpd signaling and lamellipodia formation. The control effect of SHIP2 on cell migration varies widely in different cell types. Although the reason for the differences between cells is not understood, differences in the status of other phosphoinositide phosphatases including INPP4B can affect the amounts of phosphoinositides including PIP<sub>3</sub>, PI(3,4)P<sub>2</sub>, and PI(4,5)P<sub>2</sub> and determine the function of SHIP2 in invasive phenotypes of cancer cells.</p><fig fig-type="Figure" xml:lang="en" id="cas13215-fig-0008" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Schematic representation of the distinct roles of <styled-content style="fixed-case">PI</styled-content>(3,4)P<sub>2</sub>, PI(4,5)P<sub>2</sub> and <styled-content style="fixed-case">PIP</styled-content>
<sub>3</sub> in focal adhesion formation and cell spreading in breast cancer cells. Examples of molecules known to be involved in phosphoinositide turnover and to function downstream of each phosphoinositide are shown.</p></caption><graphic id="nlm-graphic-17" xlink:href="CAS-108-941-g008"/></fig><p>Among these phosphoinositides, PI(4,5)P<sub>2</sub> increases FAK phosphorylation and facilitates directional cell migration through interaction with its effector IQ Motif Containing GTPase Activating Protein 1 (IQGAP1).<xref rid="cas13215-bib-0053" ref-type="ref">53</xref> In 1321 N1 glioblastoma cells, SHIP2 depletion increased PI(4,5)P<sub>2</sub> levels by two&#x02010;fold and facilitated FAK phosphorylation. In MDA&#x02010;MB&#x02010;231 cells, SHIP2 depletion increased the amount of PI(4,5)P<sub>2</sub> by only 20%; and we could not detect an increase in FAK phosphorylation. These results suggest that SHIP2 does not affect PI(4,5)P<sub>2</sub>&#x02010;dependent regulation of cell migration and invasion in MDA&#x02010;MB&#x02010;231 cells. Lpd was shown to be required for metastasis in an orthotopic breast cancer mouse model, and increased Lpd expression suppressed metastasis&#x02010;free survival in breast cancer patients.<xref rid="cas13215-bib-0051" ref-type="ref">51</xref> These data suggest that the inhibition of Lpd&#x02010;Rac&#x02010;WAVE pathway causes a shift from membrane ruffling and lamellipodia formation to focal adhesion development. Although underlying mechanisms of how PI(3,4)P<sub>2</sub> and its downstream effectors mediate PAX phosphorylation remain to be solved, increase in PAX phosphorylation by SHIP2 and Lpd knockdown is likely to induce development of focal adhesion and enlargement of breast cancer cell. Thus, it is possible that SHIP2 enhances the formation of PI(3,4)P<sub>2</sub>, which in turn activates Lpd, leading to increased cell invasion and metastasis.</p></sec><sec id="cas13215-sec-0020"><title>Author contribution</title><p>M. F and T. I. performed the experiments and analyzed the data. T. I and T. T designed the study and wrote the paper. All authors discussed the results and commented on the manuscript.</p></sec><sec id="cas13215-sec-0022"><title>Disclosure</title><p>The authors have no conflict of interest.</p></sec></body><back><ack id="cas13215-sec-0021"><title>Acknowledgments</title><p>We are grateful to Shunichi Nakamura (Kobe University Graduate School of Medicine) for their assistance. This work was supported by grants to T. I. from the Japan Society for the Promotion of Science (JSPS; Kakenhi grant number 16K08585). The funding agency had no role in the study design, data collection and analysis, decision to publish, or presentation of the manuscript.</p></ack><ref-list content-type="cited-references" id="cas13215-bibl-0001"><title>References</title><ref id="cas13215-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cas13215-cit-0001">
<string-name>
<surname>Krause</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gautreau</surname>
<given-names>A</given-names>
</string-name>. <article-title>Steering cell migration: lamellipodium dynamics and the regulation of directional persistence</article-title>. <source>Nat Rev Mol Cell Biol</source>
<year>2014</year>; <volume>15</volume>: <fpage>577</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">25145849</pub-id></mixed-citation></ref><ref id="cas13215-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cas13215-cit-0002">
<string-name>
<surname>Bae</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Das</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Wells</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gertler</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Roy</surname>
<given-names>P</given-names>
</string-name>. <article-title>Profilin1 regulates PI(3,4)P2 and lamellipodin accumulation at the leading edge thus influencing motility of MDA&#x02010;MB&#x02010;231 cells</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2010</year>; <volume>107</volume>: <fpage>21547</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">21115820</pub-id></mixed-citation></ref><ref id="cas13215-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cas13215-cit-0003">
<string-name>
<surname>Law</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Vehlow</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kotini</surname>
<given-names>M</given-names>
</string-name>
<italic>et al</italic>
<article-title>Lamellipodin and the Scar/WAVE complex cooperate to promote cell migration in vivo</article-title>. <source>J Cell Biol</source>
<year>2013</year>; <volume>203</volume>: <fpage>673</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">24247431</pub-id></mixed-citation></ref><ref id="cas13215-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cas13215-cit-0004">
<string-name>
<surname>Lopez&#x02010;Knowles</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>O'Toole</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>McNeil</surname>
<given-names>CM</given-names>
</string-name>
<italic>et al</italic>
<article-title>PI3K pathway activation in breast cancer is associated with the basal&#x02010;like phenotype and cancer&#x02010;specific mortality</article-title>. <source>Int J Cancer</source>
<year>2010</year>; <volume>126</volume>: <fpage>1121</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">19685490</pub-id></mixed-citation></ref><ref id="cas13215-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cas13215-cit-0005">
<string-name>
<surname>Ma</surname>
<given-names>CX</given-names>
</string-name>, <string-name>
<surname>Ellis</surname>
<given-names>MJ</given-names>
</string-name>. <article-title>The Cancer Genome Atlas: clinical applications for breast cancer</article-title>. <source>Oncology (Williston Park)</source>
<year>2013</year>; <volume>27</volume>(<issue>1263&#x02013;9</issue>): <fpage>74</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="cas13215-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cas13215-cit-0006">
<string-name>
<surname>Pang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>SP</given-names>
</string-name>
<italic>et al</italic>
<article-title>Prognostic role of PIK3CA mutations and their association with hormone receptor expression in breast cancer: a meta&#x02010;analysis</article-title>. <source>Sci Rep</source>
<year>2014</year>; <volume>4</volume>: <fpage>6255</fpage>.<pub-id pub-id-type="pmid">25176561</pub-id></mixed-citation></ref><ref id="cas13215-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cas13215-cit-0007">
<string-name>
<surname>Cuorvo</surname>
<given-names>LV</given-names>
</string-name>, <string-name>
<surname>Verderio</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ciniselli</surname>
<given-names>CM</given-names>
</string-name>
<italic>et al</italic>
<article-title>PI3KCA mutation status is of limited prognostic relevance in ER&#x02010;positive breast cancer patients treated with hormone therapy</article-title>. <source>Virchows Arch</source>
<year>2014</year>; <volume>464</volume>: <fpage>85</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">24233241</pub-id></mixed-citation></ref><ref id="cas13215-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cas13215-cit-0008">
<string-name>
<surname>Gonzalez&#x02010;Angulo</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Karuturi</surname>
<given-names>MS</given-names>
</string-name>
<italic>et al</italic>
<article-title>Frequency of mesenchymal&#x02010;epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide&#x02010;3&#x02010;kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer</article-title>. <source>Cancer</source>
<year>2013</year>; <volume>119</volume>: <fpage>7</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">22736407</pub-id></mixed-citation></ref><ref id="cas13215-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cas13215-cit-0009">
<string-name>
<surname>Stemke&#x02010;Hale</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Gonzalez&#x02010;Angulo</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Lluch</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic>
<article-title>An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer</article-title>. <source>Can Res</source>
<year>2008</year>; <volume>68</volume>: <fpage>6084</fpage>&#x02013;<lpage>91</lpage>.</mixed-citation></ref><ref id="cas13215-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cas13215-cit-0010">
<string-name>
<surname>Maehama</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Dixon</surname>
<given-names>JE</given-names>
</string-name>. <article-title>The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5&#x02010;trisphosphate</article-title>. <source>J Biol Chem</source>
<year>1998</year>; <volume>273</volume>: <fpage>13375</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">9593664</pub-id></mixed-citation></ref><ref id="cas13215-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cas13215-cit-0011">
<string-name>
<surname>Stambolic</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>de la Pompa</surname>
<given-names>JL</given-names>
</string-name>
<italic>et al</italic>
<article-title>Negative regulation of PKB/Akt&#x02010;dependent cell survival by the tumor suppressor PTEN</article-title>. <source>Cell</source>
<year>1998</year>; <volume>95</volume>: <fpage>29</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">9778245</pub-id></mixed-citation></ref><ref id="cas13215-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cas13215-cit-0012">
<string-name>
<surname>Liu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>Targeting the phosphoinositide 3&#x02010;kinase pathway in cancer</article-title>. <source>Nat Rev Drug Discovery</source>
<year>2009</year>; <volume>8</volume>: <fpage>627</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">19644473</pub-id></mixed-citation></ref><ref id="cas13215-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cas13215-cit-0013">
<string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Liaw</surname>
<given-names>D</given-names>
</string-name>
<italic>et al</italic>
<article-title>PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</article-title>. <source>Science</source>
<year>1997</year>; <volume>275</volume>: <fpage>1943</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">9072974</pub-id></mixed-citation></ref><ref id="cas13215-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cas13215-cit-0014">
<string-name>
<surname>Steck</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Pershouse</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Jasser</surname>
<given-names>SA</given-names>
</string-name>
<italic>et al</italic>
<article-title>Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers</article-title>. <source>Nat Genet</source>
<year>1997</year>; <volume>15</volume>: <fpage>356</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">9090379</pub-id></mixed-citation></ref><ref id="cas13215-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cas13215-cit-0015">
<string-name>
<surname>Liaw</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Marsh</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>
<italic>et al</italic>
<article-title>Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome</article-title>. <source>Nat Genet</source>
<year>1997</year>; <volume>16</volume>: <fpage>64</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">9140396</pub-id></mixed-citation></ref><ref id="cas13215-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cas13215-cit-0016">
<string-name>
<surname>Rhei</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bogomolniy</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Federici</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Borgen</surname>
<given-names>PI</given-names>
</string-name>, <string-name>
<surname>Boyd</surname>
<given-names>J</given-names>
</string-name>. <article-title>Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas</article-title>. <source>Can Res</source>
<year>1997</year>; <volume>57</volume>: <fpage>3657</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="cas13215-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cas13215-cit-0017">
<string-name>
<surname>Fedele</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Ooms</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Ho</surname>
<given-names>M</given-names>
</string-name>
<italic>et al</italic>
<article-title>Inositol polyphosphate 4&#x02010;phosphatase II regulates PI3K/Akt signaling and is lost in human basal&#x02010;like breast cancers</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2010</year>; <volume>107</volume>: <fpage>22231</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">21127264</pub-id></mixed-citation></ref><ref id="cas13215-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cas13215-cit-0018">
<string-name>
<surname>Gewinner</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>ZC</given-names>
</string-name>, <string-name>
<surname>Richardson</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic>
<article-title>Evidence that inositol polyphosphate 4&#x02010;phosphatase type II is a tumor suppressor that inhibits PI3K signaling</article-title>. <source>Cancer Cell</source>
<year>2009</year>; <volume>16</volume>: <fpage>115</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">19647222</pub-id></mixed-citation></ref><ref id="cas13215-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cas13215-cit-0019">
<string-name>
<surname>Bredel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bredel</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Juric</surname>
<given-names>D</given-names>
</string-name>
<italic>et al</italic>
<article-title>High&#x02010;resolution genome&#x02010;wide mapping of genetic alterations in human glial brain tumors</article-title>. <source>Can Res</source>
<year>2005</year>; <volume>65</volume>: <fpage>4088</fpage>&#x02013;<lpage>96</lpage>.</mixed-citation></ref><ref id="cas13215-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cas13215-cit-0020">
<string-name>
<surname>Liang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Diehn</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Watson</surname>
<given-names>N</given-names>
</string-name>
<italic>et al</italic>
<article-title>Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2005</year>; <volume>102</volume>: <fpage>5814</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">15827123</pub-id></mixed-citation></ref><ref id="cas13215-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cas13215-cit-0021">
<string-name>
<surname>Saxena</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Clark</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Robertson</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Ikejiri</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Oldfield</surname>
<given-names>EH</given-names>
</string-name>, <string-name>
<surname>Ali</surname>
<given-names>IU</given-names>
</string-name>. <article-title>Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas</article-title>. <source>Can Res</source>
<year>1992</year>; <volume>52</volume>: <fpage>6716</fpage>&#x02013;<lpage>21</lpage>.</mixed-citation></ref><ref id="cas13215-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cas13215-cit-0022">
<string-name>
<surname>Davies</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Kong</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic>
<article-title>Differential SKIP expression in PTEN&#x02010;deficient glioblastoma regulates cellular proliferation and migration</article-title>. <source>Oncogene</source>
<year>2015</year>; <volume>34</volume>: <fpage>3711</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">25241900</pub-id></mixed-citation></ref><ref id="cas13215-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="cas13215-cit-0023">
<string-name>
<surname>Ooms</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Binge</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Davies</surname>
<given-names>EM</given-names>
</string-name>
<italic>et al</italic>
<article-title>The Inositol Polyphosphate 5&#x02010;Phosphatase PIPP Regulates AKT1&#x02010;dependent breast cancer growth and metastasis</article-title>. <source>Cancer Cell</source>
<year>2015</year>; <volume>28</volume>: <fpage>155</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="pmid">26267533</pub-id></mixed-citation></ref><ref id="cas13215-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="cas13215-cit-0024">
<string-name>
<surname>Giuriato</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Blero</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Robaye</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Bruyns</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Payrastre</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Erneux</surname>
<given-names>C</given-names>
</string-name>. <article-title>SHIP2 overexpression strongly reduces the proliferation rate of K562 erythroleukemia cell line</article-title>. <source>Biochem Biophys Res Commun</source>
<year>2002</year>; <volume>296</volume>: <fpage>106</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">12147234</pub-id></mixed-citation></ref><ref id="cas13215-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="cas13215-cit-0025">
<string-name>
<surname>Taylor</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brandts</surname>
<given-names>C</given-names>
</string-name>
<italic>et al</italic>
<article-title>5&#x02019; phospholipid phosphatase SHIP&#x02010;2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells</article-title>. <source>Mol Cell Biol</source>
<year>2000</year>; <volume>20</volume>: <fpage>6860</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">10958682</pub-id></mixed-citation></ref><ref id="cas13215-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="cas13215-cit-0026">
<string-name>
<surname>Clement</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Krause</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Desmedt</surname>
<given-names>F</given-names>
</string-name>
<italic>et al</italic>
<article-title>The lipid phosphatase SHIP2 controls insulin sensitivity</article-title>. <source>Nature</source>
<year>2001</year>; <volume>409</volume>: <fpage>92</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">11343120</pub-id></mixed-citation></ref><ref id="cas13215-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="cas13215-cit-0027">
<string-name>
<surname>Prasad</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Topping</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Decker</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>Src family tyrosine kinases regulate adhesion&#x02010;dependent tyrosine phosphorylation of 5&#x02019;&#x02010;inositol phosphatase SHIP2 during cell attachment and spreading on collagen I</article-title>. <source>J Cell Sci</source>
<year>2002</year>; <volume>115</volume>: <fpage>3807</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">12235291</pub-id></mixed-citation></ref><ref id="cas13215-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="cas13215-cit-0028">
<string-name>
<surname>Takabayashi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Takeuchi</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic>
<article-title>LL5beta directs the translocation of filamin A and SHIP2 to sites of phosphatidylinositol 3,4,5&#x02010;triphosphate (PtdIns(3,4,5)P3) accumulation, and PtdIns(3,4,5)P3 localization is mutually modified by co&#x02010;recruited SHIP2</article-title>. <source>J Biol Chem</source>
<year>2010</year>; <volume>285</volume>: <fpage>16155</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">20236936</pub-id></mixed-citation></ref><ref id="cas13215-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="cas13215-cit-0029">
<string-name>
<surname>Edimo</surname>
<given-names>WE</given-names>
</string-name>, <string-name>
<surname>Ramos</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Vanderwinden</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Erneux</surname>
<given-names>C</given-names>
</string-name>. <article-title>The SHIP2 interactor Myo1c is required for cell migration in 1321 N1 glioblastoma cells</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2016</year>; <volume>576</volume>: <fpage>508</fpage>&#x02013;<lpage>14</lpage>.</mixed-citation></ref><ref id="cas13215-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="cas13215-cit-0030">
<string-name>
<surname>Edimo</surname>
<given-names>WE</given-names>
</string-name>, <string-name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Derua</surname>
<given-names>R</given-names>
</string-name>
<italic>et al</italic>
<article-title>SHIP2 controls plasma membrane PI(4,5)P2 thereby participating in the control of cell migration in 1321 N1 glioblastoma</article-title>. <source>J Cell Sci</source>
<year>2016</year>; <volume>129</volume>: <fpage>1101</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">26826186</pub-id></mixed-citation></ref><ref id="cas13215-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="cas13215-cit-0031">
<string-name>
<surname>Fu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Pu</surname>
<given-names>X</given-names>
</string-name>
<italic>et al</italic>
<article-title>Elevated expression of SHIP2 correlates with poor prognosis in non&#x02010;small cell lung cancer</article-title>. <source>Int J Clin Exp Pathol</source>
<year>2013</year>; <volume>6</volume>: <fpage>2185</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">24133597</pub-id></mixed-citation></ref><ref id="cas13215-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="cas13215-cit-0032">
<string-name>
<surname>Fu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Ni</surname>
<given-names>H</given-names>
</string-name>
<italic>et al</italic>
<article-title>High expression of inositol polyphosphate phosphatase&#x02010;like 1 associates with unfavorable survival in hepatocellular carcinoma</article-title>. <source>Int J Clin Exp Pathol</source>
<year>2013</year>; <volume>6</volume>: <fpage>2515</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">24228114</pub-id></mixed-citation></ref><ref id="cas13215-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="cas13215-cit-0033">
<string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>Y</given-names>
</string-name>
<italic>et al</italic>
<article-title>High SHIP2 expression indicates poor survival in colorectal cancer</article-title>. <source>Dis Markers</source>
<year>2014</year>; <volume>2014</volume>: <fpage>218968</fpage>.<pub-id pub-id-type="pmid">25525286</pub-id></mixed-citation></ref><ref id="cas13215-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="cas13215-cit-0034">
<string-name>
<surname>Hasegawa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tokuda</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tenno</surname>
<given-names>T</given-names>
</string-name>
<italic>et al</italic>
<article-title>SH3YL1 regulates dorsal ruffle formation by a novel phosphoinositide&#x02010;binding domain</article-title>. <source>J Cell Biol</source>
<year>2011</year>; <volume>193</volume>: <fpage>901</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">21624956</pub-id></mixed-citation></ref><ref id="cas13215-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="cas13215-cit-0035">
<string-name>
<surname>Sharma</surname>
<given-names>VP</given-names>
</string-name>, <string-name>
<surname>Eddy</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Entenberg</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kai</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gertler</surname>
<given-names>FB</given-names>
</string-name>, <string-name>
<surname>Condeelis</surname>
<given-names>J</given-names>
</string-name>. <article-title>Tks5 and SHIP2 regulate invadopodium maturation, but not initiation, in breast carcinoma cells</article-title>. <source>Curr Biol</source>
<year>2013</year>; <volume>23</volume>: <fpage>2079</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">24206842</pub-id></mixed-citation></ref><ref id="cas13215-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="cas13215-cit-0036">
<string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Hou</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic>
<article-title>Phosphatidylinositol&#x02010;3,4&#x02010;bisphosphate and its binding protein lamellipodin regulate chemotaxis of malignant B lymphocytes</article-title>. <source>J Immunol</source>
<year>2016</year>; <volume>196</volume>: <fpage>586</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">26695371</pub-id></mixed-citation></ref><ref id="cas13215-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="cas13215-cit-0037">
<string-name>
<surname>Hawkins</surname>
<given-names>PT</given-names>
</string-name>, <string-name>
<surname>Stephens</surname>
<given-names>LR</given-names>
</string-name>. <article-title>Emerging evidence of signalling roles for PI(3,4)P2 in Class I and II PI3K&#x02010;regulated pathways</article-title>. <source>Biochem Soc Trans</source>
<year>2016</year>; <volume>44</volume>: <fpage>307</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">26862220</pub-id></mixed-citation></ref><ref id="cas13215-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="cas13215-cit-0038">
<string-name>
<surname>Chen</surname>
<given-names>XJ</given-names>
</string-name>, <string-name>
<surname>Squarr</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Stephan</surname>
<given-names>R</given-names>
</string-name>
<italic>et al</italic>
<article-title>Ena/VASP proteins cooperate with the WAVE complex to regulate the actin cytoskeleton</article-title>. <source>Dev Cell</source>
<year>2014</year>; <volume>30</volume>: <fpage>569</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">25203209</pub-id></mixed-citation></ref><ref id="cas13215-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="cas13215-cit-0039">
<string-name>
<surname>Hansen</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Mullins</surname>
<given-names>RD</given-names>
</string-name>. <article-title>Lamellipodin promotes actin assembly by clustering Ena/VASP proteins and tethering them to actin filaments</article-title>. <source>eLife</source>. <year>2015</year>. doi: <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06585">10.7554/eLife.06585</ext-link>
</mixed-citation></ref><ref id="cas13215-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="cas13215-cit-0040">
<string-name>
<surname>Chen</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Alonso</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Ostuni</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Whitesides</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Ingber</surname>
<given-names>DE</given-names>
</string-name>. <article-title>Cell shape provides global control of focal adhesion assembly</article-title>. <source>Biochem Biophys Res Commun</source>
<year>2003</year>; <volume>307</volume>: <fpage>355</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">12859964</pub-id></mixed-citation></ref><ref id="cas13215-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="cas13215-cit-0041">
<string-name>
<surname>Kanchanawong</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Shtengel</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pasapera</surname>
<given-names>AM</given-names>
</string-name>
<italic>et al</italic>
<article-title>Nanoscale architecture of integrin&#x02010;based cell adhesions</article-title>. <source>Nature</source>
<year>2010</year>; <volume>468</volume>: <fpage>580</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">21107430</pub-id></mixed-citation></ref><ref id="cas13215-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="cas13215-cit-0042">
<string-name>
<surname>Bae</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Mui</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>BY</given-names>
</string-name>
<italic>et al</italic>
<article-title>A FAK&#x02010;Cas&#x02010;Rac&#x02010;lamellipodin signaling module transduces extracellular matrix stiffness into mechanosensitive cell cycling</article-title>. <source>Science Signaling</source>
<year>2014</year>; <volume>7</volume>: <fpage>ra57</fpage>.<pub-id pub-id-type="pmid">24939893</pub-id></mixed-citation></ref><ref id="cas13215-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="cas13215-cit-0043">
<string-name>
<surname>Yamashita</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ichikawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Matsuyama</surname>
<given-names>D</given-names>
</string-name>
<italic>et al</italic>
<article-title>The role of the interaction of the vinculin proline&#x02010;rich linker region with vinexin alpha in sensing the stiffness of the extracellular matrix</article-title>. <source>J Cell Sci</source>
<year>2014</year>; <volume>127</volume>: <fpage>1875</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">24554436</pub-id></mixed-citation></ref><ref id="cas13215-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="cas13215-cit-0044">
<string-name>
<surname>Furutani</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Itoh</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ijuin</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tsujita</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Takenawa</surname>
<given-names>T</given-names>
</string-name>. <article-title>Thin layer chromatography&#x02010;blotting, a novel method for the detection of phosphoinositides</article-title>. <source>J Biochem</source>
<year>2006</year>; <volume>139</volume>: <fpage>663</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">16672266</pub-id></mixed-citation></ref><ref id="cas13215-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="cas13215-cit-0045">
<string-name>
<surname>Basson</surname>
<given-names>MD</given-names>
</string-name>. <article-title>An intracellular signal pathway that regulates cancer cell adhesion in response to extracellular forces</article-title>. <source>Cancer Res</source>
<year>2008</year>; <volume>68</volume>: <fpage>2</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">18172287</pub-id></mixed-citation></ref><ref id="cas13215-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="cas13215-cit-0046">
<string-name>
<surname>Calderwood</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Shattil</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Ginsberg</surname>
<given-names>MH</given-names>
</string-name>. <article-title>Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling</article-title>. <source>J Biol Chem</source>
<year>2000</year>; <volume>275</volume>: <fpage>22607</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">10801899</pub-id></mixed-citation></ref><ref id="cas13215-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="cas13215-cit-0047">
<string-name>
<surname>Parsons</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Slack</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Taylor</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Weed</surname>
<given-names>SA</given-names>
</string-name>. <article-title>Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement</article-title>. <source>Oncogene</source>
<year>2000</year>; <volume>19</volume>: <fpage>5606</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">11114741</pub-id></mixed-citation></ref><ref id="cas13215-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="cas13215-cit-0048">
<string-name>
<surname>Burridge</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Turner</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Romer</surname>
<given-names>LH</given-names>
</string-name>. <article-title>Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly</article-title>. <source>J Cell Biol</source>
<year>1992</year>; <volume>119</volume>: <fpage>893</fpage>&#x02013;<lpage>903</lpage>.<pub-id pub-id-type="pmid">1385444</pub-id></mixed-citation></ref><ref id="cas13215-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="cas13215-cit-0049">
<string-name>
<surname>Wang</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Basson</surname>
<given-names>MD</given-names>
</string-name>. <article-title>Akt directly regulates focal adhesion kinase through association and serine phosphorylation: implication for pressure&#x02010;induced colon cancer metastasis</article-title>. <source>Am J Physiol&#x02010;Cell Ph</source>
<year>2011</year>; <volume>300</volume>: <fpage>C657</fpage>&#x02013;<lpage>70</lpage>.</mixed-citation></ref><ref id="cas13215-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="cas13215-cit-0050">
<string-name>
<surname>Dowler</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Currie</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Campbell</surname>
<given-names>DG</given-names>
</string-name>
<italic>et al</italic>
<article-title>Identification of pleckstrin&#x02010;homology&#x02010;domain&#x02010;containing proteins with novel phosphoinositide&#x02010;binding specificities</article-title>. <source>Biochem J</source>
<year>2000</year>; <volume>351</volume>: <fpage>19</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">11001876</pub-id></mixed-citation></ref><ref id="cas13215-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="cas13215-cit-0051">
<string-name>
<surname>Carmona</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Perera</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Gillett</surname>
<given-names>C</given-names>
</string-name>
<italic>et al</italic>
<article-title>Lamellipodin promotes invasive 3D cancer cell migration via regulated interactions with Ena/VASP and SCAR/WAVE</article-title>. <source>Oncogene</source>. <year>2016</year>; <volume>35</volume>: <fpage>5155</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="pmid">26996666</pub-id></mixed-citation></ref><ref id="cas13215-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="cas13215-cit-0052">
<string-name>
<surname>Sosa</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Lopez&#x02010;Haber</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>C</given-names>
</string-name>
<italic>et al</italic>
<article-title>Identification of the Rac&#x02010;GEF P&#x02010;Rex1 as an essential mediator of ErbB signaling in breast cancer</article-title>. <source>Mol Cell</source>
<year>2010</year>; <volume>40</volume>: <fpage>877</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">21172654</pub-id></mixed-citation></ref><ref id="cas13215-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="cas13215-cit-0053">
<string-name>
<surname>Choi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Thapa</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Hedman</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Sacks</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>RA</given-names>
</string-name>. <article-title>IQGAP1 is a novel phosphatidylinositol 4,5 bisphosphate effector in regulation of directional cell migration</article-title>. <source>EMBO J</source>
<year>2013</year>; <volume>32</volume>: <fpage>2617</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">23982733</pub-id></mixed-citation></ref></ref-list></back></article>